NL1024616A1 - Depotpreparaten in de vorm van een suspensie. - Google Patents

Depotpreparaten in de vorm van een suspensie.

Info

Publication number
NL1024616A1
NL1024616A1 NL1024616A NL1024616A NL1024616A1 NL 1024616 A1 NL1024616 A1 NL 1024616A1 NL 1024616 A NL1024616 A NL 1024616A NL 1024616 A NL1024616 A NL 1024616A NL 1024616 A1 NL1024616 A1 NL 1024616A1
Authority
NL
Netherlands
Prior art keywords
suspension
depot preparations
depot
preparations
Prior art date
Application number
NL1024616A
Other languages
English (en)
Other versions
NL1024616C (nl
Inventor
Jaymin Chandrakant Shah
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL1024616A1 publication Critical patent/NL1024616A1/nl
Application granted granted Critical
Publication of NL1024616C publication Critical patent/NL1024616C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL1024616A 2002-10-25 2003-10-24 Depotpreparaten in de vorm van een suspensie. NL1024616C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42129502P 2002-10-25 2002-10-25
US42129502 2002-10-25

Publications (2)

Publication Number Publication Date
NL1024616A1 true NL1024616A1 (nl) 2004-04-27
NL1024616C NL1024616C (nl) 2010-04-19

Family

ID=32176696

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1024616A NL1024616C (nl) 2002-10-25 2003-10-24 Depotpreparaten in de vorm van een suspensie.

Country Status (21)

Country Link
US (1) US20040146562A1 (nl)
EP (1) EP1562546A1 (nl)
JP (2) JP2006505579A (nl)
KR (1) KR20050071611A (nl)
CN (1) CN1703198A (nl)
AR (1) AR041826A1 (nl)
AU (1) AU2003267763A1 (nl)
BR (1) BR0315663A (nl)
CA (1) CA2498276A1 (nl)
GT (1) GT200300227A (nl)
MX (1) MXPA05004299A (nl)
NL (1) NL1024616C (nl)
NO (1) NO20051187L (nl)
PA (1) PA8586301A1 (nl)
PE (1) PE20040471A1 (nl)
PL (1) PL375603A1 (nl)
RU (1) RU2292207C2 (nl)
TW (1) TW200418477A (nl)
UY (1) UY28035A1 (nl)
WO (1) WO2004037224A1 (nl)
ZA (1) ZA200501979B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2322953T3 (es) 2002-08-20 2009-07-02 Bristol-Myers Squibb Company Formulacion del complejo de aripiprazol y procedimiento.
PT2218448E (pt) 2002-12-13 2016-01-26 Durect Corp Sistema oral de entrega de fármaco que compreende materiais transportadores líquidos de alta viscosidade
WO2004100955A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Anxiety treatments with ziprasidone
WO2006000913A1 (en) * 2004-06-23 2006-01-05 Pfizer Products Inc. Method for sterile filtration of viscous pharmaceutical compositions
SI2415484T1 (sl) 2004-09-17 2014-10-30 Durect Corporation Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem
WO2006096462A1 (en) * 2005-03-03 2006-09-14 Elan Pharma International Limited Nanoparticulate compositions of heterocyclic amide derivatives
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
CN100391458C (zh) * 2006-02-07 2008-06-04 上海医药工业研究院 齐拉西酮或其盐包合物制备方法
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
EP3326621A1 (en) * 2007-12-06 2018-05-30 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US9555113B2 (en) 2013-03-15 2017-01-31 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
WO2018153315A1 (zh) * 2017-02-23 2018-08-30 上海华汇拓医药科技有限公司 一种多奈哌齐半帕莫酸盐的粉针剂、包含其的组合物及它们的制备方法
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989002265A1 (en) * 1987-09-07 1989-03-23 Teijin Limited Medicine-containing fat emulsion of the type prepared immediately before use and process for preparing medicine-containing fat emulsion
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
JP3954115B2 (ja) * 1992-07-28 2007-08-08 アストラゼネカ・アクチエボラーグ 注射剤および注射剤キット
US5594141A (en) * 1994-11-23 1997-01-14 Neurogen Corporation Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
UA57734C2 (uk) * 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
DE69730902T2 (de) * 1996-05-07 2006-02-23 Pfizer Inc. Verfahren zur Selektion eines Salzes zur Herstellung eines Inklusionskomplexes
DK0959873T3 (da) * 1996-12-20 2006-07-03 Alza Corp Gelsammensætning og fremgangsmåder
AU7491898A (en) * 1997-05-16 1998-12-08 Amgen, Inc. Sustained-release delayed gels
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
AU777413B2 (en) * 1999-05-27 2004-10-14 Pfizer Products Inc. Ziprasidone suspension
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
US20030055023A1 (en) * 2001-03-20 2003-03-20 Rajewski Roger A. Formulations containing etomidate and a sulfoalkyl ether cyclodextrin
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
JP2005508625A (ja) * 2001-08-31 2005-04-07 ザ ロックフェラー ユニバーシティー 抗精神病薬の分類方法

Also Published As

Publication number Publication date
PA8586301A1 (es) 2004-05-07
KR20050071611A (ko) 2005-07-07
WO2004037224A1 (en) 2004-05-06
ZA200501979B (en) 2006-04-26
MXPA05004299A (es) 2005-08-03
RU2292207C2 (ru) 2007-01-27
NO20051187L (no) 2005-04-11
TW200418477A (en) 2004-10-01
CN1703198A (zh) 2005-11-30
US20040146562A1 (en) 2004-07-29
GT200300227A (es) 2004-06-23
AR041826A1 (es) 2005-06-01
RU2005112202A (ru) 2005-11-20
AU2003267763A1 (en) 2004-05-13
JP2006505579A (ja) 2006-02-16
BR0315663A (pt) 2005-08-30
JP2006219501A (ja) 2006-08-24
NL1024616C (nl) 2010-04-19
PL375603A1 (en) 2005-12-12
CA2498276A1 (en) 2004-05-06
PE20040471A1 (es) 2004-08-14
EP1562546A1 (en) 2005-08-17
UY28035A1 (es) 2004-05-31

Similar Documents

Publication Publication Date Title
NL300974I2 (nl) Binimetinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat
NL300863I2 (nl) Palbociclib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout
NL1024616A1 (nl) Depotpreparaten in de vorm van een suspensie.
IL172653A0 (en) Novel ??-actin and rps21 promoters and uses thereof
GB0304358D0 (en) Navigator 2.0 features
BR0312136B1 (pt) artigo ornamental.
PL366887A1 (en) Thrust booster
NL1025932C2 (nl) 3-Azabicycloó3.2.1!octaanderivaten.
ITMI20032392A1 (it) Contenitore portafiala.
ITMO20020233A1 (it) Mezzi contenitori.
NL1019697A1 (nl) Stroomafnemer.
EP1642586A4 (en) CELLULAR PREPARATIONS
FR2853639B1 (fr) Aiguillage pneumatique.
NL1026828A1 (nl) Derivaten van azachinazoline.
ITTO20030435A1 (it) Automotore overhead combinato.
ES1052162Y (es) Contenedor para ostricultura y similares.
ES1054220Y (es) Compresa anti-hemorroides.
BR8302604Y1 (pt) expositor portador de artigos.
ITMI20021715A1 (it) Pelle sintetica modellabile.
GB0308617D0 (en) Happy hangers
ES1055489Y (es) Articulo de presentacion.
ITMI20022106A1 (it) Carrello portabagagli.
ES1054240Y (es) Mueble expositor.
ITRM20030537A1 (it) Integratore radio-filo.
ES1051000Y (es) Pesadora dinamica.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20100216

V1 Lapsed because of non-payment of the annual fee

Effective date: 20110501